BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martirosyan A, Aminov R, Manukyan G. Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation. Front Immunol 2019;10:1609. [PMID: 31354742 DOI: 10.3389/fimmu.2019.01609] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Current Opinion in Immunology 2023;80:102266. [DOI: 10.1016/j.coi.2022.102266] [Reference Citation Analysis]
2 van Mourik DJM, Salet DM, Middeldorp S, Nieuwdorp M, van Mens TE. The role of the intestinal microbiome in antiphospholipid syndrome. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.954764] [Reference Citation Analysis]
3 Timofeeva AM, Sedykh SE, Ermakov EA, Matveev AL, Odegova EI, Sedykh TA, Shcherbakov DN, Merkuleva IA, Volosnikova EA, Nesmeyanova VS, Tikunova NV, Nevinsky GA. Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune. IJMS 2022;23:13681. [DOI: 10.3390/ijms232213681] [Reference Citation Analysis]
4 Belyaeva IV, Kosova AN, Vasiliev AG. Tuberculosis and Autoimmunity. Pathophysiology 2022;29:298-318. [PMID: 35736650 DOI: 10.3390/pathophysiology29020022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Serrano M, Espinosa G, Cervera R, Serrano A. COVID-19 coagulopathy and antiphospholipid syndrome. Revista Colombiana de Reumatología 2022;29:S25-S34. [DOI: 10.1016/j.rcreu.2021.02.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Vandevelde A, Devreese KMJ. Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances. J Clin Med 2022;11:2164. [PMID: 35456258 DOI: 10.3390/jcm11082164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gérardin C, Bihan K, Salem JE, Khachatryan H, Gerothiofas G, Fain O, Mekinian A. Drug-induced antiphospholipid syndrome: Analysis of from the WHO international database. Autoimmun Rev 2022;:103060. [PMID: 35114404 DOI: 10.1016/j.autrev.2022.103060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Su Z, Huang Z, Zhao J, Li M, Hu J, Zeng X, Hu C, Yang B. Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study. Clin Appl Thromb Hemost 2022;28:10760296221081129. [PMID: 35379020 DOI: 10.1177/10760296221081129] [Reference Citation Analysis]
9 Karrow NA, Shandilya UK, Pelech S, Wagter-Lesperance L, McLeod D, Bridle B, Mallard BA. Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development. Vaccines (Basel) 2021;9:1351. [PMID: 34835282 DOI: 10.3390/vaccines9111351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liu T, Dai J, Yang Z, Yu X, Xu Y, Shi X, Wei D, Tang Z, Xu G, Xu W, Liu Y, Shi C, Ni Q, Yang C, Zhang X, Wang X, Chen E, Qu J. Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort. Sci Bull (Beijing) 2021. [PMID: 34336365 DOI: 10.1016/j.scib.2021.07.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
11 Yassin A, Ghzawi A, Al-Mistarehi AH, El-Salem K, Y Benmelouka A, M Sherif A, BenhadjDahman N, AlAdamat N, Jemel A, Negida A, Abdelmonem M. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021;7:FSO713. [PMID: 34254031 DOI: 10.2144/fsoa-2021-0036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
12 Magoon N, Bindu B, Sapra H. Incidental diagnosis of antiphospholipid antibody syndrome (APS) in a trauma patient with thrombocytopenia & its anesthetic management. Trauma Case Rep 2021;33:100488. [PMID: 33997231 DOI: 10.1016/j.tcr.2021.100488] [Reference Citation Analysis]
13 Bertin D, Brodovitch A, Beziane A, Mege JL, Heim X, Bardin N. Reply. Arthritis Rheumatol 2021;73:899-900. [DOI: 10.1002/art.41633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dieudonné Y, Guffroy A, Poindron V, Sprauel PS, Martin T, Korganow AS, Gies V. B cells in primary antiphospholipid syndrome: Review and remaining challenges. Autoimmun Rev 2021;20:102798. [PMID: 33722752 DOI: 10.1016/j.autrev.2021.102798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kaplan MJ. Linking clotting and autoimmunity. Science 2021;371:1100-1. [PMID: 33707252 DOI: 10.1126/science.abg6449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Karahan S, Erol K, Yuksel RC, Artan C, Celik I. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit. Mod Rheumatol 2021;:1-10. [PMID: 33620009 DOI: 10.1080/14397595.2021.1892257] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
17 Jansen VL, Gerdes VE, Middeldorp S, van Mens TE. Gut microbiota and their metabolites in cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2021;35:101492. [PMID: 33642219 DOI: 10.1016/j.beem.2021.101492] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
18 Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect 2021;54:37-45. [PMID: 33500211 DOI: 10.1016/j.jmii.2020.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 James JA. The role of infections in SLE pathogenesis. Lahita's Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-820583-9.00018-x] [Reference Citation Analysis]
20 Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res 2021;232:13-36. [PMID: 33352298 DOI: 10.1016/j.trsl.2020.12.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
21 Sayar Z, Moll R, Isenberg D, Cohen H. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management. Thromb Res 2021;198:213-21. [PMID: 33485122 DOI: 10.1016/j.thromres.2020.10.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
22 Ferrari E, Sartre B, Squara F, Contenti J, Occelli C, Lemoel F, Levraut J, Doyen D, Dellamonica J, Mondain V, Chirio D, Risso K, Cua E, Orban JC, Ichai C, Labbaoui M, Mossaz B, Moceri P, Appert-Flory A, Fischer F, Toulon P. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019. J Am Heart Assoc 2020;9:e017773. [PMID: 32972320 DOI: 10.1161/JAHA.120.017773] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
23 Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 2020;39:2811-5. [PMID: 32720260 DOI: 10.1007/s10067-020-05310-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 25.0] [Reference Citation Analysis]
24 Vonck K, Garrez I, De Herdt V, Hemelsoet D, Laureys G, Raedt R, Boon P. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2. Eur J Neurol 2020;27:1578-87. [PMID: 32416028 DOI: 10.1111/ene.14329] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 30.5] [Reference Citation Analysis]
25 Manukyan G, Martirosyan A, Slavik L, Ulehlova J, Dihel M, Papajik T, Kriegova E. 17β-Estradiol Promotes Proinflammatory and Procoagulatory Phenotype of Innate Immune Cells in the Presence of Antiphospholipid Antibodies. Biomedicines 2020;8:E162. [PMID: 32549383 DOI: 10.3390/biomedicines8060162] [Reference Citation Analysis]
26 Manukyan G, Martirosyan A, Slavik L, Margaryan S, Ulehlova J, Mikulkova Z, Hlusi A, Papajik T, Kriegova E. Anti-domain 1 β2 glycoprotein antibodies increase expression of tissue factor on monocytes and activate NK Cells and CD8+ cells in vitro. Auto Immun Highlights 2020;11:5. [PMID: 32127041 DOI: 10.1186/s13317-020-00128-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Cheemalavagu S, McCoy SS, Knight JS. Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome. BMJ Case Rep 2020;13:e232907. [PMID: 32041760 DOI: 10.1136/bcr-2019-232907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]